<DOC>
	<DOCNO>NCT02385461</DOCNO>
	<brief_summary>The occurrence spontaneous fetal loss ( FL ) rather frequent event : estimate 15 % pregnancy result fetal loss . However , recurrent event , define &gt; 2 &gt; 3 loss , depend guideline use ( American College Obstetricians Gynecologists Royal College Obstetricians Gynaecologists guideline ) , occur 1 % pregnancy noteworthy Recurrent Fetal Loss ( RFL ) 30-40 % case remain unexplained standard gynaecological , hormonal karyotype investigation . Furthermore , important consider chromosomal abnormality responsible least 60 % FL first trimester , thus abnormal karyotype fetus exclude prior consider test woman genetic susceptibility placental vascular complication ( inherit thrombophilia ) . Common inherit condition , factor V Leiden ( FV ) factor II G20210A ( FII ) mutation recognize risk factor FL . The efficacy treatment antithrombotic drug pregnancy woman history RFL/ Intra Uterine Fetal Death ( IUFD ) thrombophilia still debate , due scarcity available data . Italian guideline suggest use Low-Molecular-Weight Heparin ( LMWH ) woman FV FII mutation previous otherwise unexplained obstetric complication , guideline release RCOG suggest heparin therapy pregnancy may improve live birth rate woman second trim loss associate inherited thrombophilias . Hence , idea propose prospective observational study compare clinical data outcome woman common inherited thrombophilias woman without . During study investigator collect evaluate clinical data examination visit patient , eligible study carrier thrombophilic defect . This observation begin pregnancy continue puerperium , allow u study possible factor influence condition . The study add knowledge improve feto-maternal prognosis prevent spontaneous recurrent FL . Plan study : multicenter observational study</brief_summary>
	<brief_title>Study Antithrombotic Prevention Thrombophilia Pregnancy Loss</brief_title>
	<detailed_description />
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Thrombophilia</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>recurrent otherwise unexplained FL ( define &gt; 3 , 2 presence least 1 normal fetal karyotype ) ( accord Lussana et al . ) least 1 intrauterine fetal death ( IUFD ) , define loss 20 week morphologically normal fetus with/without HETEROZYGOUS FOR FACTOR V LEIDEN HETEROZYGOUS FOR FIIA20210 ( PTm ) personal history venous and/or arterial thromboembolism ; document hemorrhagic disease ; allergy LMWH ; uterine abnormality ; cervical incompetence ; untreated endocrine disease ( diabetes mellitus thyroid disease ) ; indication anticoagulant treatment pregnancy ; chromosomal abnormality parent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>